4-Methoxy-1-indanone structure
|
Common Name | 4-Methoxy-1-indanone | ||
---|---|---|---|---|
CAS Number | 13336-31-7 | Molecular Weight | 162.185 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 303.0±31.0 °C at 760 mmHg | |
Molecular Formula | C10H10O2 | Melting Point | 105-107 °C (dec.)(lit.) | |
MSDS | Chinese USA | Flash Point | 145.4±18.4 °C |
Name | 4-Methoxy-1-indanone |
---|---|
Synonym | More Synonyms |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 303.0±31.0 °C at 760 mmHg |
Melting Point | 105-107 °C (dec.)(lit.) |
Molecular Formula | C10H10O2 |
Molecular Weight | 162.185 |
Flash Point | 145.4±18.4 °C |
Exact Mass | 162.068085 |
PSA | 26.30000 |
LogP | 2.28 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.564 |
Storage condition | 2~8°C |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Hazard Codes | Xn |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 2914509090 |
~99% 4-Methoxy-1-indanone CAS#:13336-31-7 |
Literature: Tanaka; Murakami; Okuda; Kuroda; Inoue; Kamei; Murata; Yoshino; Imanishi; Iwata Chemical and Pharmaceutical Bulletin, 1994 , vol. 42, # 9 p. 1756 - 1759 |
~77% 4-Methoxy-1-indanone CAS#:13336-31-7 |
Literature: Sterling Winthrop Inc. Patent: US5554620 A1, 1996 ; |
~96% 4-Methoxy-1-indanone CAS#:13336-31-7 |
Literature: Cannon, Joseph G.; Dushin, Russell G.; Long, John Paul; Ilhan, Mustafa; Jones, Noel D.; Swartzendruber, John K. Journal of Medicinal Chemistry, 1985 , vol. 28, # 4 p. 515 - 518 |
~% 4-Methoxy-1-indanone CAS#:13336-31-7 |
Literature: Journal of Medicinal Chemistry, , vol. 28, # 4 p. 515 - 518 |
~% 4-Methoxy-1-indanone CAS#:13336-31-7 |
Literature: Journal of Medicinal Chemistry, , vol. 28, # 4 p. 515 - 518 |
~% 4-Methoxy-1-indanone CAS#:13336-31-7 |
Literature: Journal of Medicinal Chemistry, , vol. 28, # 4 p. 515 - 518 |
Precursor 6 | |
---|---|
DownStream 6 | |
HS Code | 2914509090 |
---|---|
Summary | HS:2914509090 other ketones with other oxygen function VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
Conformationally constrained analogues ofN′-(4-tert-butylbenzyl)-N-(4-methylsulfonylaminobenzyl)thiourea as TRPV1 antagonists
Eur. J. Med. Chem. 44(1) , 322-31, (2009) A series of bicyclic analogues having indan and tetrahydronaphthalene templates in the A-region were designed as conformationally constrained analogues of our previously reported potent TRPV1 antagoni... |
|
Radioiodination of aryl-alkyl cyclic sulfates.
J. Org. Chem. 65 , 7158-7174, (2000) Among the currently available positron emitters suitable for Positron Emission Tomography (PET), (124)I has the longest physical half-life (4.2 days). The long half-life and well-investigated behavior... |
|
Modification of oxidative status in Plasmodium berghei-infected erythrocytes by E-2-chloro-8-methyl-3-[(4'-methoxy-1'-indanoyl)-2'-methyliden]-quinoline compared to chloroquine.
Mem. Inst. Oswaldo Cruz 104(6) , 865-70, (2009) E-2-chloro-8-methyl-3-[(4'-methoxy-1'-indanoyl)-2'-methyliden]-quinoline (IQ) is a new quinoline derivative which has been reported as a haemoglobin degradation and ss-haematin formation inhibitor. Th... |
4-methoxy-2,3-dihydroinden-1-one |
4-methoxy-2,3-dihydro-1H-inden-1-one |
4-Methoxy-2,3-dihydro-1H-inden-1-on |
4-methoxyindan-1-one |
1H-Inden-1-one, 2,3-dihydro-4-methoxy- |
4-Methoxy-1-indanone |
MFCD00192268 |
4-methoxy-2,3-dihydroinden-1-one;4-Methoxyindan-1-one |